PDSB: PDS Biotechnology Corp Net earnings per share (EPS TTM)

PDS Biotechnology Corporation (PDSB) - corporate logo

PDS Biotechnology faces a dependency on the Versamune test results and external financing. The TTM net income per share distribution reflects earnings dynamics, with the parameter stabilizing at -0.64. The company's innovative ecosystem integrates vaccines and immunotherapy to combat metastases. The stability of the R&D core is ensured by an effective incentive system for leading oncologists and researchers.

PDSB PDS Biotechnology Net earnings per share for the last 12 months (07/04/2022 - 11/12/2026)

Summary analytical data breakdowns for PDS Biotech (PDSB)

- share price and expert price forecast:
Stock Quotes PDS Biotechnology Corp|PDSB - Fair Value Consensus
- market capitalization information:
Market Capitalization PDS Biotechnology Corporation|PDSB - Company Buyout Price
- business book valuation details:
Net Assets per Single Share PDS Biotechnology|PDSB - Company Net Assets|Market Value to Book Value Ratio pdsbiotech.com|PDSB - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio PDS Biotechnology|PDSB - Long-Term Debt to Capital|Short-Term Debt to Equity PDS Biotechnology Corp|PDSB - Company Aggregate Debt|Debt to Book Capitalization Ratio PDS Biotechnology Corporation|PDSB - Long-Term Debt|Company Current Liabilities PDS Biotechnology|Quick Liquidity Indicator pdsbiotech.com
- earnings and multiples data:
PDSB - Profit After Payment of Taxes|Projected Future Earnings PDS Biotechnology|PDSB - Company Value to Net Income|Forward P/E Multiple PDS Biotechnology Corp|PDSB - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PDS Biotechnology Corporation|PDSB - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) PDS Biotechnology|PDSB - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months pdsbiotech.com|PDSB - Earnings per share trend in current year|Expected earnings per share growth for next year PDS Biotechnology
Fundamental valuation:PDSB - pdsbiotech.com
Flagship merchandise of PDS Biotechnology Corp

Net income per share (TTM) measures the actual business profitability distributed per share over a trailing twelve-month period. By analyzing the annual net income per share trend via GURU.Markets, an investor can observe the current balance of supply and demand. This metric is calculated by dividing the total annual income by the total number of shares outstanding. For PDS Biotechnology (PDSB), this indicator is critical during the implementation of robotic biomolecule screening. The automation of oncology drug development should optimize costs, directly impacting the future dynamics of this fundamental value.

Main competitors

IBRX: Net earnings per share for the last 12 months|Earnings per share for the trailing year IMCR (immunocore.com)|JANX: Net earnings per share (EPS TTM)|RCUS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Zymeworks Corp|Net earnings per share for the last 12 months Tango Therapeutics Corp (TNGX)|Earnings per share for the last twelve months Iovance Biotherapeutics (IOVA)|Net earnings per share for the last 12 months immatics.com IMTX|Xencor - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Compass Therapeutics Inc CMPX|REPL - Earnings per share for the last twelve months|LYEL (Lyell Pharma) - Earnings per share for the last 12 months|Innate Pharma S.A. (IPHA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Pyxis Oncology (PYXS)|Net earnings per share for the last 12 months CGEN|IOBT - Net earnings per share for the trailing year|Net earnings per share for the last 12 months STRO (Sutro Bio)|Earnings per share for the last four quarters INKT|Net earnings per share (EPS TTM) HOWL (Werewolf Therapeutics, Inc.)|Earnings per share for the trailing year IMMX|ALX Oncology Holdings - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months cuebiopharma.com|sonnetbio.com (SONN) - Earnings per share for the last twelve months|MAIA Bio - Earnings per share for the trailing year|LIMN (Liminatus Pharma) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Lava Tx|Earnings per share for the last twelve months NextCure (NXTC)|LPTX: Earnings per one share for the last 12 months|Intensity Therapeutics, Inc. - Net earnings per share for the last 12 months|Sensei Biotherapeutics Inc (SNSE) - Net earnings per one share for the last twelve months|TOVX - Earnings per share for the last twelve months|Earnings per one share for the last 12 months GRTS|KA: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months NEXI|Earnings per share for the last twelve months Turnstone Biologics Corp|Vaccinex Inc (VCNX) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months HARP (Harpoon Therapeutics)